Enhancement of equine infectious anemia virus virulence by identification and removal of suboptimal nucleotides

Virology

Volumn 313, Issue 2, 2003, Pages 588-603

  Cook, R Frank ^a   Cook, Sheila J ^a   Berger, Sandra L ^a   Leroux, Caroline ^b,d   Ghabrial, Nadia N ^a   Gantz, Marie ^c   Bolin, Pamela S ^a   Mousel, Michelle R ^a   Montelaro, Ronald C ^b   Issel, Charles J ^a  

^a UNIVERSITY OF KENTUCKY   (United States)

^b UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

^c UNIVERSITY OF KENTUCKY   (United States)

^d UNIVERSITÉ LYON 1   (France)

Author keywords

EIAV; Infectious molecular clones; Nucleotide sequence; Pathogenesis

Indexed keywords

NUCLEOTIDE;

ARTICLE; CONTROLLED STUDY; CORRELATION ANALYSIS; EQUINE INFECTIOUS ANEMIA VIRUS; GENE DUPLICATION; GENE SEQUENCE; MOLECULAR CLONING; NONHUMAN; NUCLEOTIDE SEQUENCE; PATHOGENICITY; PRIORITY JOURNAL; VIRUS IDENTIFICATION; VIRUS INFECTION; VIRUS VIRULENCE;

EQUIDAE; EQUINE INFECTIOUS ANEMIA VIRUS; EQUUS; EQUUS CABALLUS;

EID: 0041384505     PISSN: 00426822     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0042-6822(03)00351-9     Document Type: Article

References (50)

1. Alexandersen S., Carpenter S. Characterization of variable regions in the envelope and S3 open reading frame of equine infectious anemia virus. J. Virol. 65:1991;4255-4262.
2. Belshan M., Harris M.E., Shoemaker A.E., Hope T.J., Carpenter S. Biological characterization of rev variation in equine infectious anemia virus. J. Virol. 72:1998;4421-4426.
3. Belshan M., Baccam P., Oaks J.L., Sponsellor B.A., Murphy S.C., Cornette J., Carpenter S. Genetic and virological variation in equine infectious anemia virus rev correlates with variable stages of clinical disease in an experimentally infected pony. Virology. 279:2001;185-200.
4. Carroll R., Martarano L., Derse D. Identification of lentivirus tat functional domains through generation of equine infectious anemia virus/human immunodeficiency virus type 1 tat gene chimeras. J. Virol. 65:1991;3460-3467.
5. Carvalho M., Derse D. Physical and functional characterization of transcriptional control elements in the equine infectious anemia virus promoter. J. Virol. 67:1993;2064-2074.
6. Carvalho M., Kirkland M.M., Derse D. Protein interactions with DNA elements in variant equine infectious anemia virus enhancers and their impact on transcriptional activity. J. Virol. 67:1993;6586-6595.
7. Chen C., Li F., Montelaro R.C. Functional roles of equine infectious anemia virus gag p9 in viral budding and infection. J. Virol. 75:2001;9762-9770.
8. Cook R.F., Cook S.J., Issel C.J. A non-radioactive micro-assay for released reverse transcriptase activity of a lentivirus. BioTechniques. 13:1992;380-386.
9. Cook R.F., Issel C.J., Montelaro R.C. Equine infectious anemia. Studdert J.J. Virus Infections of Equines. 1996;297-323 Elsevier, Amsterdam.
10. Cook R.F., Leroux C., Cook S.J., Berger S.L., Lichtenstein D.L., Ghabrial N.N., Montelaro R.C., Issel C.J. Development and characterization of an in vivo pathogenic molecular clone of equine infectious anemia virus. J. Virol. 72:1998;1383-1393.
11. Cook R.F., Cook S.J., Li F., Montelaro R.C., Issel C.J. Development of a multiplex real-time reverse transcriptase-polymerase chain reaction for equine infectious anemia virus (EIAV). J. Virol. Meth. 105:2002;171-179.
12. Costa L.R.R., de Miranda Santos I.K.F., Issel C.J., Montelaro R.C. Tumor necrosis factor-α production and disease severity after immunization with enriched major core protein (p26) and /or infection with equine infectious anemia virus. Vet. Immunol. Immunopathol. 57:1997;33-47.
13. Cunningham T.P., Montelaro R.C., Rushlow K.E. Lentivirus envelope sequences and proviral genomes are stabilized in Escherichia coli when cloned in low-copy-number plasmid vectors. Gene. 124:1993;93-98.
14. Derse D., Dorn P.L., Levy L., Stephens R.M., Rice N.R., Casey J.W. Characterization of equine infectious anemia virus long terminal repeat. J. Virol. 61:1987;743-747.
15. De Vico A.L., Montelaro R.C., Gallo R.C., Samgadharan M.G. Purification and partial characterization of equine infectious anemia virus reverse transcriptase. Virology. 185:1991;387-394.
16. Dorn P., DaSilva L., Martarano L., Derse D. Equine infectious anemia virus tat Insights into the structure, function and evolution of lentivirus trans-activator proteins . J. Virol. 64:1990;1616-1624.
17. Dougherty, R.M., (1964) In: Techniques in Experimental Virology, Harris, R.J.C., pp. 169-220, Academic Press, London, England.
18. Duarte E.A., Novella I.S., Ledesma S., Clarke D.K., Moya A., Elena S.F., Domino E., Holland J.J. Subclonal components of consensus fitness in an RNA virus clone. J. Virol. 68:1994;4295-4301.
19. Hammond S.A., Cook S.J., Lichtenstein D.L., Issel C.J., Montelaro R.C. Maturation of the cellular and humoral immune responses to persistent infection in horses by equine infectious anemia virus is a complex and lengthy process. J. Virol. 71:1997;3840-3852.
20. Issel C.J., Horohov D.W., Lea D.F., Adams W.V. Jr, Hagius S.D., McManus J.M., Allison A.C., Montelaro R.C. Efficacy of inactivated whole-virus and subunit vaccines in preventing infection and disease caused by equine infectious anemia virus. J. Virol. 66:1992;3398-3408.
21. Kemeny L.J., Mott L.O., Pearson J.E. Titration of equine infectious anemia virus. Effect of dosage on incubation time and clinical signs. Cornell Vet. 61:1971;687-695.
22. Klein D., Leutenegger C.M., Bahula C., Gold P., Hofmann-Lehmann R., Salmons B., Lutz H., Gunzburg W.H. Influence of preassay and sequence variations on viral load determination by a multiplex real-time reverse transcriptase-polymerase chain reaction for feline immunodeficiency virus. J. AIDS. 26:2001;8-20.
23. Leroux C., Issel C.J., Montelaro R.C. Novel and dynamic evolution of equine infectious anemia virus genomic quasispecies associated with sequential disease cycles in an experimentally infected pony. J. Virol. 71:1997;9627-9639.
24. Li F., Leroux C., Craigo J.K., Cook S.J., Issel C.J., Montelaro R.C. The S2 gene of equine infectious anemia is a highly conserved determinant of viral replication and virulence properties in experimentally infected ponies. J. Virol. 74:2000;573-579.
25. Li F., Chen C., Puffer B.A., Montelaro R.C. Functional replacement and positional dependence of homologous and heterologous L domains in equine infectious anemia virus replication. J. Virol. 76:2002;1569-1577.
26. Lichtenstein D.L., Issel C.J., Montelaro R.C. Genomic quasispecies associated with the initiation of infection and disease in ponies experimentally infected with equine infectious anemia virus. J. Virol. 70:1996;3346-3354.
27. Malmquist W.A., Barnett D., Becvar C.S. Production of equine infectious anemia antigen in a persistently infected cell line. Arch. Virol. 42:1973;361-370.
28. Martarano L., Stephens R., Rice N., Derse D. Equine infectious anemia virus trans-regulatory protein rev controls viral mRNA stability, accumulation and alternative splicing. J. Virol. 68:1994;3102-3111.
29. Maury W. Monocyte maturation controls expression of equine infectious anemia virus. J. Virol. 68:1994;6270-6279.
30. Maury W. Regulation of equine infectious anemia virus expression. J. Biomed. Sci. 5:1998;11-23.
31. McGuire T.C., Tumas D.B., Byrne K.M., Hines M.T., Leib S.R., Brassfield A.L., O'Rourke K.I., Perryman L.E. Major histocompatibility complex-restricted CD8+ cytotoxic T lymphocytes from horses with equine infectious anemia virus recognize Env and Gag/PR proteins. J. Virol. 68:1994;1459-1467.
32. Mealey R.H., Fraser D.G., Oaks J.L., Cantor G.H., McGuire T.C. Immune reconstitution prevents continuous equine infectious anemia virus replication in an Arabian foal with severe combined immunodeficiency lessons for control of lentiviruses . Clin. Immunol. 101:2001;237-247.
33. Meyer B.E., Meinkoth J.L., Malim M.H. Nuclear transport of human immunodeficiency virus type 1, visna virus, and equine infectious anemia virus rev proteins identification of a family of transferable nuclear export signals . J. Virol. 70:1996;2350-2359.
34. Montelaro R.C., Ball J.M., Rushlow K.E. Equine retroviruses. Levy J. The Retroviridae. Vol 2:1993;257-360 Plenum, New York.
35. Noiman S., Gazit A., Tori O., Sherman L., Miki T., Tronick S.R., Yaniv A. Identification of sequences encoding the equine infectious anemia virus tat gene. Virology. 176:1990;280-288.
36. Orrego A., Issel C.J., Montelaro R.C., Adams W.V. Jr. Virulence and in vitro growth of cell-adapted strain of equine infectious anemia virus after serial passage in ponies. Am. J. Vet. Res. 43:1982;1556-1560.
37. Perryman L.E., O'Rourke K.I., McGuire T.C. Immune responses are required to terminate viremia in equine infectious anemia lentivirus infection. J. Virol. 62:1988;3073-3076.
38. Puffer B.A., Parent L.J., Wills J.W., Montelaro R.C. Equine infectious anemia virus utilizes a YXXL motif within the late assembly domain of the gag p9 protein. J. Virol. 71:1997;6541-6546.
39. Quandt K., Frech K., Karas H., Wingender E., Werner T. MatInd and MatInspector - new fast and versatile tools for detection of consensus matches in nucleotide sequence data. Nucleic Acids Res. 23:1995;4878-4884.
40. Raabe M.R., Issel C.J., Montelaro R.C. Equine monocyte-derived macrophage cultures and their applications for infectivity and neutralization studies of equine infectious anemia virus. J. Virol. Methods. 71:1998;87-104.
41. Rosin-Arbesfeld R., Rivlin M., Noiman S., Mashiah P., Yaniv A., Miki T., Tronick S.R., Gazit A. Structural and functional characterization of rev - like transcripts of equine infectious anemia virus. J. Virol. 67:1993;5640-5646.
42. Rosin-Arbesfeld R., Willbold D., Yaniv A., Gazit A. The tat protein of equine infectious anemia virus (EIAV) activates cellular gene expression by read-through transcription. Gene. 219:1998;25-35.
43. Rwambo P.M., Issel C.J., Hussain K.A., Montelaro R.C. In vitro isolation of a neutralization escape mutant of equine infectious anemia virus. Arch. Virol. 111:1990;275-280.
44. Saman E., Breugelmans K., Heyndrickx L., Merreagaert J. The open reading frame ORF S3 of equine infectious anemia virus is expressed during the viral life cycle. J. Virol. 64:1990;6319-6324.
45. Sellon D.C., Fuller F.J., McGuire T.C. The immunopathogenesis of equine infectious anemia virus. Virus Res. 32:1994;111-138.
46. Sellon D.C., Russel K.E., Monroe V.L., Walker K.M. Increased interleukin-6 activity in the serum of ponies acutely infected with equine infectious anemia virus. Res. Vet. Sci. 66:1998;77-80.
47. Stephens R.M., Casey J.W., Rice N.R. Equine infectious anemia virus gag and pol genes relatedness to Visna and AIDS virus . Science. 231:1986;589-594.
48. Tornquist S.J., Oaks J.L., Crawford T.B. Elevation of cytokines associated with the thrombocytopenia of equine infectious anemia. J. Gen. Virol. 78:1997;2541-2548.
49. Wang S.Z., Rushlow K.E., Issel C.J., Cook R.F., Cook S.J., Raabe M.L., Chong Y.H., Costa L., Montelaro R.C. Enhancement of EIAV replication and disease by immunization with a baculovirus-expressed recombinant envelope surface glycoprotein. Virology. 199:1994;247-251.
50. Wohrl B.M., Howard K.J., Jacques P.S., Le Grice S.F.J. Alternative modes of polymerization distinguish the subunits of equine infectious anemia virus reverse transcriptase. J. Biol. Chem. 269:1994;8541-8548.